Purchases and Sales Made in Q3 2022 in Supernus Pharmaceuticals, Inc. (SUPN)
This table provides information about the institutional ownership of Supernus Pharmaceuticals, Inc. (SUPN) during Q3 2022. The information is specifically focused on institutions that hold shares of SUPERNUS PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Oct 31, 2022
Q3 2022
|
Sg Americas Securities, LLC
|
SELL
|
- |
-35.7K- 78.56% |
$1.03M - $1.26M
|
9.74K
$384K
|
|
|
Nov 14, 2022
Q3 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-42.7K- 16.87% |
$1.23M - $1.51M
|
210K
$8.31M
|
|
|
Nov 14, 2022
Q3 2022
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-43.6K- 66.3% |
$1.25M - $1.54M
|
22.1K
$874K
|
|
|
Nov 08, 2022
Q3 2022
|
New York State Common Retirement Fund
|
SELL
|
- |
-46K- 19.03% |
$1.32M - $1.63M
|
196K
$7.72M
|
|
|
Nov 14, 2022
Q3 2022
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-47.9K- 7.02% |
$1.38M - $1.7M
|
634K
$25M
|
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-54.9K- 2.77% |
$1.58M - $1.94M
|
1.92M
$75.9M
|
|
|
Nov 15, 2022
Q3 2022
|
Bruce & Co., Inc.
Chicago, IL |
SELL
|
- |
-80K- 39.58% |
$2.3M - $2.83M
|
122K
$4.82M
|
|
|
May 14, 2024
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-85.8K- 27.89% |
$2.47M - $3.04M
|
222K
$8.75M
|
|
|
Nov 10, 2022
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-85.8K- 27.89% |
$2.47M - $3.04M
|
222K
$8.75M
|
|
|
Nov 14, 2022
Q3 2022
|
Aristotle Capital Boston, LLC
Boston, MA |
SELL
|
- |
-110K- 8.69% |
$3.17M - $3.9M
|
1.16M
$45.7M
|
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-117K- 8.36% |
$3.36M - $4.14M
|
1.28M
$50.5M
|
|
|
Nov 14, 2022
Q3 2022
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-119K- 2.53% |
$3.43M - $4.21M
|
4.59M
$181M
|
|
|
Nov 09, 2022
Q3 2022
|
Gw&K Investment Management, LLC
Boston, MA |
SELL
|
- |
-142K- 7.45% |
$4.1M - $5.04M
|
1.77M
$69.8M
|
|
|
Nov 01, 2022
Q3 2022
|
Rice Hall James & Associates, LLC
|
SELL
|
- |
-155K- 18.54% |
$4.45M - $5.48M
|
679K
$26.8M
|